RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
As of 05:36PM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 836.73M |
| Enterprise value | 633.79M |
| Trailing P/E | 21.55 |
| Forward P/E | 42.02 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.57 |
| Price/book (mrq) | 0.67 |
| Enterprise value/revenue | 0.43 |
| Enterprise value/EBITDA | 5.42 |
Trading information
Stock price history
| Beta (5Y monthly) | -0.03 |
| 52-week change 3 | -4.62% |
| S&P500 52-week change 3 | 24.49% |
| 52-week high 3 | 14.00 |
| 52-week low 3 | 9.50 |
| 50-day moving average 3 | 11.57 |
| 200-day moving average 3 | 11.20 |
Share statistics
| Avg vol (3-month) 3 | 4.21k |
| Avg vol (10-day) 3 | 7.7k |
| Shares outstanding 5 | 66.94M |
| Implied shares outstanding 6 | 66.94M |
| Float 8 | 5.15M |
| % held by insiders 1 | 92.27% |
| % held by institutions 1 | 0.70% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.15 |
| Forward annual dividend yield 4 | 1.20% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 1.94 |
| Payout ratio 4 | 25.86% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 08 Jun 2023 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 13 Jul 2007 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 2.23% |
| Operating margin (ttm) | 4.31% |
Management effectiveness
| Return on assets (ttm) | 1.40% |
| Return on equity (ttm) | 3.17% |
Income statement
| Revenue (ttm) | 1.73B |
| Revenue per share (ttm) | 25.92 |
| Quarterly revenue growth (yoy) | 4.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 101.5M |
| Net income avi to common (ttm) | 38.71M |
| Diluted EPS (ttm) | 0.58 |
| Quarterly earnings growth (yoy) | 77.50% |
Balance sheet
| Total cash (mrq) | 342.84M |
| Total cash per share (mrq) | 5.12 |
| Total debt (mrq) | 149.84M |
| Total debt/equity (mrq) | 11.70% |
| Current ratio (mrq) | 2.35 |
| Book value per share (mrq) | 18.70 |
Cash flow statement
| Operating cash flow (ttm) | 109M |
| Levered free cash flow (ttm) | 22.36M |
© 2024 Yahoo. All rights reserved.